Clinical Trial Update: PETACC-8 miR-31-3p and miR-31-5p Ancillary Study [Phase 3]

View source ↗

Summary

An ancillary Phase 3 study within the PETACC-8 program evaluating microRNAs miR-31-3p and miR-31-5p in colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• miR-31-3p
• miR-31-5p

Snippet

Sponsor: IntegraGen SA | Conditions: Colorectal Cancer | Phase 3 | Status: COMPLETED